Exelixis Inc
$13.96B- Market cap
- $14.62B
- Debt
- +$399.32M
- Cash
- −$1.06B
Capital structure 97% equity / 3% debt · EV / Revenue 6.02x · EV / EBITDA 14.83x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $14.62B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: EXEL stock price near parity vs BKH $59.01 current versus $51.14 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BKH's multiple
Implied fair value · at EXEL's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EXEL FY 2026 (ended Jan 2, 2026) · BKH FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 97% equity / 3% debt · EV / Revenue 6.02x · EV / EBITDA 14.83x
Capital structure 54% equity / 46% debt · EV / Revenue 4.37x · EV / EBITDA 13.78x
EXEL carries the larger enterprise value at $13.96B against $10.10B; BKH trades on the lower EV / Revenue multiple (4.37x vs 6.02x); BKH on the lower EV / EBITDA (13.78x vs 14.83x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Exelixis Inc · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Black Hills Corporation · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.18x
1.23x
Net debt / EBITDA
Leverage against operating earnings
-0.70x
6.16x
Cash and equivalents
Liquid reserves on the balance sheet
$1.06B
$182.80M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
EXEL vs AMGN
BIOGEN INC.
EXEL vs BIIB
GILEAD SCIENCES, INC.
EXEL vs GILD
INCYTE CORP
EXEL vs INCY
Sarepta Therapeutics, Inc.
EXEL vs SRPT
ALLETE INC
EXEL vs ALE
IDACORP INC
EXEL vs IDA
NISOURCE INC.
EXEL vs NI
PINNACLE WEST CAPITAL CORP
EXEL vs PNW
Duke Energy CORP
EXEL vs DUK
Evergy, Inc.
EXEL vs EVRG
$399.32M
$4.70B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.